⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ASMB News
Assembly Biosciences, Inc
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in
globenewswire.com
ASMB
GILD
Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
AMGN
PFE
LLY
AZN
BMY
NVS
SNY
GSK
UCB
ARQT
REGN
INCY
ABBV
BIIB
MRK
JNJ
VNDA
RAPT
CHAI
ONON
ION
ASMB
CRVS
APG
KSCP
KYMR
XBI
IBB
ADSK
CDNS
SNPS
Comanche Biopharma Appoints Richard Colvin, MD, PhD as Global Head of R&D and John McHutchison, AO, MD as Chairman and Director of Comanche Biopharma Australia
globenewswire.com
CBIO
BBIO
NVS
TUNE
VELI
ASMB
GILD
Dealership Buy/Sell Market on Pace for Another Record Year as Valuations and Earnings Climb in the Third Quarter
businesswire.com
GM
ASMB
HOG
F
SUB
HMC
STLA
TM
NSANY
BMWYY
MBGYY
VOW
RIVN
LCID
TSLA
CHEVY
BUICK
JAGUY
TTM
7203.T
7201.T
7267.T
7259.T
7122.T
7205.T
7270.T
7261.T
7277.T
Assembly Biosciences Reports Third Quarter 2025 Financial Results and Recent Updates
globenewswire.com
ASMB
Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting®
globenewswire.com
ASMB
Assembly Biosciences Announces Upcoming Investor Conference Participation
globenewswire.com
ASMB
Assembly Biosciences Presents Interim Phase 1b Data for HSV Helicase-Primase Inhibitor Candidate ABI-5366 at the 38th Congress of the International Union Against Sexually Transmitted Infections (IUSTI)- Europe
globenewswire.com
ASMB